Fyn, a potential target for Alzheimer's disease.

Alzheimer's disease (AD) is the most common form of dementia characterized by the presence of amyloid-β (Aβ) plaques and neurofibrillary tangles. The mechanisms leading to AD are not completely understood; however, recent evidence suggests that alterations in Fyn, a Src family kinase, might contribute to AD pathogenesis. A number of studies have demonstrated that Fyn is involved in synaptic plasticity, a cellular mechanism for learning and memory. In addition, Fyn plays a role in the regulation of Aβ production and mediates Aβ-induced synaptic deficits and neurotoxicity. Fyn also induces tyrosine phosphorylation of tau. Although many studies have implicated a role for Fyn in AD, the precise cellular and molecular mechanisms require further investigation. Novel insights into the role of Fyn in AD may help identify alternative pharmacological approaches for the treatment of AD.

[1]  R. Malenka,et al.  AMPA receptor trafficking and synaptic plasticity. , 2002, Annual review of neuroscience.

[2]  K. Roche,et al.  Regulation of NMDA receptors by phosphorylation , 2007, Neuropharmacology.

[3]  J. Jia,et al.  Association between NR2B subunit gene (GRIN2B) promoter polymorphisms and sporadic Alzheimer’s disease in the North Chinese population , 2009, Neuroscience Letters.

[4]  K. Obata,et al.  Enhanced synaptic transmission and reduced threshold for LTP induction in fyn‐transgenic mice , 1999, The European journal of neuroscience.

[5]  R. Malinow,et al.  β-Amyloid Modulation of Synaptic Transmission and Plasticity , 2007, The Journal of Neuroscience.

[6]  R. Anwyl,et al.  Glun2b Subunit-containing Nmda Receptor Antagonists Prevent A␤-mediated Synaptic Plasticity Disruption in Vivo Abrogation of A␤-mediated Disruption of Hippocampal Synaptic Plasticity in Vivo by Antagonists Selective for Glun2b-containing , 2022 .

[7]  W. K. Cullen,et al.  Alzheimer’s Disease Amyloid β-Protein and Synaptic Function , 2010, NeuroMolecular Medicine.

[8]  R. Petralia,et al.  Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Wood,et al.  The protein tyrosine kinase, fyn, in Alzheimer's disease pathology , 1993, Neuroreport.

[10]  T. Pawson,et al.  Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. , 1993, Oncogene.

[11]  S. Nakanishi,et al.  PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Shimizu,et al.  Genetic enhancement of learning and memory in mice , 1999, Nature.

[13]  D. Bowtell,et al.  The Cbl Proto-Oncogene Product Negatively Regulates the Src-Family Tyrosine Kinase Fyn by Enhancing Its Degradation , 2000, Molecular and Cellular Biology.

[14]  C. Pallen,et al.  PTPα Activates Lyn and Fyn and Suppresses Hck to Negatively Regulate FcεRI-Dependent Mast Cell Activation and Allergic Responses , 2010, The Journal of Immunology.

[15]  L. Mucke,et al.  Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[16]  D. Verbanac,et al.  Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes. , 2007, Journal of medicinal chemistry.

[17]  D. Hanger,et al.  Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  R. Jope,et al.  Insulin Transiently Increases Tau Phosphorylation , 1999, Journal of neurochemistry.

[19]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.

[20]  Michael W. Salter,et al.  Src kinases: a hub for NMDA receptor regulation , 2004, Nature Reviews Neuroscience.

[21]  D. Coulter,et al.  Fyn-mediated Phosphorylation of NR2B Tyr-1336 Controls Calpain-mediated NR2B Cleavage in Neurons and Heterologous Systems* , 2007, Journal of Biological Chemistry.

[22]  S. Yen,et al.  Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy , 2010, Neuropathology and applied neurobiology.

[23]  P Riederer,et al.  Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[24]  S. Davis,et al.  What can rodent models tell us about cognitive decline in alzheimer’s disease? , 2003, Molecular Neurobiology.

[25]  Masahiko Watanabe,et al.  Impairment of Suckling Response, Trigeminal Neuronal Pattern Formation, and Hippocampal LTD in NMDA Receptor ε2 Subunit Mutant Mice , 1996, Neuron.

[26]  Sheila M. Thomas,et al.  Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.

[27]  K. Roche,et al.  Molecular determinants of NMDA receptor internalization , 2001, Nature Neuroscience.

[28]  P. Davies,et al.  Binding of Fyn to MAP-2c through an SH3 Binding Domain , 2001, The Journal of Biological Chemistry.

[29]  E R Kandel,et al.  Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Chao,et al.  A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling , 2006, Molecular and Cellular Neuroscience.

[31]  Angus C. Nairn,et al.  Synaptic plasticity: one STEP at a time , 2006, Trends in Neurosciences.

[32]  S. Yen,et al.  Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.

[33]  L. Mucke,et al.  Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice , 2004, The Journal of Neuroscience.

[34]  B. Hyman,et al.  Fyn Modulation of Dab1 Effects on Amyloid Precursor Protein and ApoE Receptor 2 Processing* , 2008, Journal of Biological Chemistry.

[35]  S. Lindquist,et al.  Laminin Alters Fyn Regulatory Mechanisms and Promotes Oligodendrocyte Development , 2009, The Journal of Neuroscience.

[36]  H. Band,et al.  An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn. , 2002, Signal transduction.

[37]  T. Mittmann,et al.  Reduced presynaptic efficiency of excitatory synaptic transmission impairs LTP in the visual cortex of BDNF‐heterozygous mice , 2006, The European journal of neuroscience.

[38]  E. Kandel,et al.  Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.

[39]  Fei Liu,et al.  Microtubule-associated protein tau in development, degeneration and protection of neurons , 2008, Progress in Neurobiology.

[40]  I. Everall,et al.  Rapid Tyrosine Phosphorylation of Neuronal Proteins Including Tau and Focal Adhesion Kinase in Response to Amyloid-β Peptide Exposure: Involvement of Src Family Protein Kinases , 2002, The Journal of Neuroscience.

[41]  M. Resh.  Interaction of tyrosine kinase oncoproteins with cellular membranes. , 1993, Biochimica et biophysica acta.

[42]  Masahiko Watanabe,et al.  NMDA Receptor GluN2B (GluRε2/NR2B) Subunit Is Crucial for Channel Function, Postsynaptic Macromolecular Organization, and Actin Cytoskeleton at Hippocampal CA3 Synapses , 2009, The Journal of Neuroscience.

[43]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[44]  M. Salter.  Src, N-methyl-D-aspartate (NMDA) receptors, and synaptic plasticity. , 1998, Biochemical pharmacology.

[45]  M. Giordano,et al.  Beta‐amyloid protein (25–35) disrupts hippocampal network activity: Role of Fyn‐kinase , 2009, Hippocampus.

[46]  C. Thornton,et al.  Mind Bomb-2 Is an E3 Ligase That Ubiquitinates the N-Methyl-d-aspartate Receptor NR2B Subunit in a Phosphorylation-dependent Manner* , 2008, Journal of Biological Chemistry.

[47]  T. Atkinson,et al.  Identification of an alternatively spliced isoform of the fyn tyrosine kinase. , 2002, Biochemical and biophysical research communications.

[48]  Gloria Lee.  Tau and src family tyrosine kinases. , 2005, Biochimica et biophysica acta.

[49]  J. Baik,et al.  The Novel Cellular Mechanism of Human 5-HT6 Receptor through an Interaction with Fyn* , 2007, Journal of Biological Chemistry.

[50]  C. Duyckaerts,et al.  The microtubule-associated protein tau is also phosphorylated on tyrosine. , 2009, Journal of Alzheimer's disease : JAD.

[51]  G. V. Van Hoesen,et al.  Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.

[52]  Yitao Liu,et al.  Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.

[53]  Zhen Yan,et al.  Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex , 2005, The Journal of Neuroscience.

[54]  David G Standaert,et al.  Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. , 2004, Molecular pharmacology.

[55]  R. Malinow,et al.  AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.

[56]  J. Kuriyan,et al.  Structures of Src-family tyrosine kinases. , 1997, Current opinion in structural biology.

[57]  David G Standaert,et al.  Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking , 2006, The Journal of Neuroscience.

[58]  I. Black,et al.  Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation , 2006, Brain Research.

[59]  A. Bode,et al.  Myricetin suppresses UVB-induced skin cancer by targeting Fyn. , 2008, Cancer research.

[60]  M. Citron,et al.  Alzheimer's disease: strategies for disease modification , 2010, Nature Reviews Drug Discovery.

[61]  Cook Mp,et al.  Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. , 1989 .

[62]  W. Song,et al.  Phosphorylation of Ser 21 in Fyn regulates its kinase activity, focal adhesion targeting, and is required for cell migration , 2011, Journal of cellular physiology.

[63]  R. Roskoski,et al.  Src kinase regulation by phosphorylation and dephosphorylation. , 2005, Biochemical and biophysical research communications.

[64]  Kai Chang,et al.  The Synaptic Localization of NR2B-Containing NMDA Receptors Is Controlled by Interactions with PDZ Proteins and AP-2 , 2005, Neuron.

[65]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[66]  M. Ward,et al.  Tyrosine Phosphorylation of Tau by the Src Family Kinases Lck and Fyn , 2011, Molecular Neurodegeneration.

[67]  M. Baudry,et al.  Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially modulates their susceptibility to calpain and enhances their binding to spectrin and PSD‐95 , 2001, Journal of neurochemistry.

[68]  Ying-Chen Yang,et al.  Focal Adhesion Kinase Is Required, But Not Sufficient, for the Induction of Long-Term Potentiation in Dentate Gyrus Neurons In Vivo , 2003, The Journal of Neuroscience.

[69]  L. Minichiello.  TrkB signalling pathways in LTP and learning , 2009, Nature Reviews Neuroscience.

[70]  José María Delgado-García,et al.  Associative Learning and CA3–CA1 Synaptic Plasticity Are Impaired in D1R Null, Drd1a−/− Mice and in Hippocampal siRNA Silenced Drd1a Mice , 2010, The Journal of Neuroscience.

[71]  H. Band,et al.  Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.

[72]  E. Kandel,et al.  Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice. , 1998, Learning & memory.

[73]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[74]  Jürgen Götz,et al.  Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.

[75]  E. Kandel,et al.  Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. , 1995, Genes & development.

[76]  P. Lombroso,et al.  The role of STEP in Alzheimer's disease , 2010 .

[77]  D. Purpura,et al.  NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders , 2007, Nature Reviews Neuroscience.

[78]  M. Resh,et al.  Morphological Differentiation of Oligodendrocytes Requires Activation of Fyn Tyrosine Kinase , 1999, The Journal of cell biology.

[79]  C. Duarte,et al.  Regulation of AMPA receptors and synaptic plasticity , 2009, Neuroscience.

[80]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[81]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[82]  Wendy Noble,et al.  Tyrosine 394 Is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with c-Abl as the Candidate Tyrosine Kinase , 2005, The Journal of Neuroscience.

[83]  Michael P. Mazanetz,et al.  Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases , 2007, Nature Reviews Drug Discovery.

[84]  E. Ingley,et al.  Src family kinases: regulation of their activities, levels and identification of new pathways. , 2008, Biochimica et biophysica acta.

[85]  K. Reymann,et al.  Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors , 2011, Neurobiology of Aging.

[86]  T. Yamamoto,et al.  Growth factor-mediated Fyn signaling regulates alpha-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression in rodent neocortical neurons. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[88]  S. Mangiavacchi,et al.  Mechanisms by which Dopamine Receptors May Influence Synaptic Plasticity , 2003, Annals of the New York Academy of Sciences.

[89]  A. Palmeri,et al.  Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.

[90]  T. Smithgall,et al.  Small molecule inhibitors of Lck: the search for specificity within a kinase family. , 2008, Mini reviews in medicinal chemistry.

[91]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[92]  D. Selkoe,et al.  Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.

[93]  Shoji Komai,et al.  Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.

[94]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[95]  A. Scaloni,et al.  Platelet-derived Growth Factor Induces the β-γ-Secretase-mediated Cleavage of Alzheimer's Amyloid Precursor Protein through a Src-Rac-dependent Pathway* , 2003, The Journal of Biological Chemistry.

[96]  Wenjun Gao,et al.  Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons , 2010, Molecular Brain.

[97]  J. Marshall,et al.  Structural elements that regulate pp59c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen , 1991, Journal of virology.

[98]  J. Pessin,et al.  Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity? , 2009, Archives of physiology and biochemistry.

[99]  K. Roche,et al.  Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression , 2003, Neuropharmacology.

[100]  Masahiko Watanabe,et al.  NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity , 2006, The EMBO journal.

[101]  Mun Kyung Hwang,et al.  Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha. , 2009, Biochemical pharmacology.

[102]  P. Lombroso,et al.  Striatal Enriched Phosphatase 61 Dephosphorylates Fyn at Phosphotyrosine 420* , 2002, The Journal of Biological Chemistry.

[103]  L. Thal,et al.  Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role , 2005, Neurobiology of Aging.

[104]  J. Rawlins,et al.  Contribution of Hippocampal and Extra-Hippocampal NR2B-Containing NMDA Receptors to Performance on Spatial Learning Tasks , 2008, Neuron.

[105]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[106]  E. Mandelkow,et al.  Fyn-Tau-Amyloid: A Toxic Triad , 2010, Cell.

[107]  L. Shaw,et al.  SHP2 Mediates the Localized Activation of Fyn Downstream of the α6β4 Integrin To Promote Carcinoma Invasion , 2010, Molecular and Cellular Biology.

[108]  R. Johns,et al.  Post-synaptic density-93 mediates tyrosine-phosphorylation of the N-methyl-d-aspartate receptors , 2008, Neuroscience.

[109]  R. Finn,et al.  SRC: a century of science brought to the clinic. , 2010, Neoplasia.

[110]  Xian-Min Yu,et al.  NMDA Channel Regulation by Channel-Associated Protein Tyrosine Kinase Src , 1997, Science.